drugset

drugset / Trial / NCT01541735

Pantoprazole on Insulin Secretion in Diabetes

NCT01541735 ↗

Phase 2/3 Completed 14 enrolled Coordinación de Investigación en Salud, Mexico

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to evaluate the effect of pantoprazole on insulin secretion in drug-naïve patients with type 2 diabetes.

Timeline

Start: 2012-01
Primary completion: 2013-03
Completion: 2013-05

Publications

Gonzalez-Ortiz M, Martinez-Abundis E, Mercado-Sesma AR, Alvarez-Carrillo R. Effect of pantoprazole on insulin secretion in drug-naive patients with type 2 diabetes. Diabetes Res Clin Pract. 2015 Apr;108(1):e11-3. doi: 10.1016/j.diabres.2015.01.039. Epub 2015 Feb 7.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pantoprazole	Other / unclassified	40 mg	—

Indications